glp-1 agonist in esrd receptor agonists and next-generation metabolic hormone therapies chronic kidney disease CKJ REVIEW GLP-1 receptor agonists
Description
[DOI] [PubMed] [Google Scholar] 162.Li Q., Yang Q., Han J., Liu X., Fu J., Yin J
The glucagon advantage
Founds clinicians, trained in obesity medicine, can help patients identify the root cause of their weight gain and personalize a prescription to target it
Questions of value Jimmy Joe (we just love that name!) tells a similar story
Exendin-4 (10 nM) promotes the expression of serine protease inhibitor-9, thus underlying the survival capability of cells against the attack of immune cells such as natural killer cells and cytotoxic T cells in human islets (Cechin et al., 2012)
